Cargando…
Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda
OBJECTIVES: To what extent is DMPA-SC reaching new users versus encouraging method switching among existing users? Though increasingly-popular, little is known about characteristics of women using DMPA-SC in SSA. We compared characteristics of women using DMPA-SC with those of other modern methods,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846921/ https://www.ncbi.nlm.nih.gov/pubmed/33554107 http://dx.doi.org/10.1016/j.conx.2021.100055 |
_version_ | 1783644833943912448 |
---|---|
author | Anglewicz, Philip Larson, Elizabeth Akilimali, Pierre Guiella, Georges Kayembe, Patrick Kibira, Simon P.S. Makumbi, Fredrick Radloff, Scott |
author_facet | Anglewicz, Philip Larson, Elizabeth Akilimali, Pierre Guiella, Georges Kayembe, Patrick Kibira, Simon P.S. Makumbi, Fredrick Radloff, Scott |
author_sort | Anglewicz, Philip |
collection | PubMed |
description | OBJECTIVES: To what extent is DMPA-SC reaching new users versus encouraging method switching among existing users? Though increasingly-popular, little is known about characteristics of women using DMPA-SC in SSA. We compared characteristics of women using DMPA-SC with those of other modern methods, and identified the extent to which women using DMPA-SC switched from another method or are first-time users of contraception. STUDY DESIGN: We used data collected by the Performance Monitoring for Action (PMA) Project between 2016 and 2019 from three countries, Burkina Faso, Democratic Republic of Congo, and Uganda. We tabulated characteristics of DMPA-SC, DMPA-IM, implant, and male condom users, and used multivariate analysis to compare characteristics of women using DMPA-SC those of the other three methods. We also examined previous contraceptive method use (if any) among women currently using DMPA-SC. RESULTS: We found that never-married women were more likely to use male condoms instead of DMPA-SC. Women with two or more children (compared to no children or one child) were more likely to use implants instead of DMPA-SC in both Uganda and DRC. DMPA-SC was the first method used by the majority of current users in Burkina Faso and Uganda. DMPA-SC users who previously used another method generally switched from less effective methods. CONCLUSIONS: Although the characteristics of women using DMPA-SC varied across countries, DMPA-SC appears to be reaching new populations of women instead of inspiring existing modern users to switch to DMPA-SC, and appears to be appealing to first time users of contraception. IMPLICATIONS: It appears that DMPA-SC appeals to new contraceptive users in sub-Saharan Africa, which implies that DMPA-SC may have the potential to increase modern contraceptive prevalence in sub-Saharan African countries. |
format | Online Article Text |
id | pubmed-7846921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-78469212021-02-04 Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda Anglewicz, Philip Larson, Elizabeth Akilimali, Pierre Guiella, Georges Kayembe, Patrick Kibira, Simon P.S. Makumbi, Fredrick Radloff, Scott Contracept X Article OBJECTIVES: To what extent is DMPA-SC reaching new users versus encouraging method switching among existing users? Though increasingly-popular, little is known about characteristics of women using DMPA-SC in SSA. We compared characteristics of women using DMPA-SC with those of other modern methods, and identified the extent to which women using DMPA-SC switched from another method or are first-time users of contraception. STUDY DESIGN: We used data collected by the Performance Monitoring for Action (PMA) Project between 2016 and 2019 from three countries, Burkina Faso, Democratic Republic of Congo, and Uganda. We tabulated characteristics of DMPA-SC, DMPA-IM, implant, and male condom users, and used multivariate analysis to compare characteristics of women using DMPA-SC those of the other three methods. We also examined previous contraceptive method use (if any) among women currently using DMPA-SC. RESULTS: We found that never-married women were more likely to use male condoms instead of DMPA-SC. Women with two or more children (compared to no children or one child) were more likely to use implants instead of DMPA-SC in both Uganda and DRC. DMPA-SC was the first method used by the majority of current users in Burkina Faso and Uganda. DMPA-SC users who previously used another method generally switched from less effective methods. CONCLUSIONS: Although the characteristics of women using DMPA-SC varied across countries, DMPA-SC appears to be reaching new populations of women instead of inspiring existing modern users to switch to DMPA-SC, and appears to be appealing to first time users of contraception. IMPLICATIONS: It appears that DMPA-SC appeals to new contraceptive users in sub-Saharan Africa, which implies that DMPA-SC may have the potential to increase modern contraceptive prevalence in sub-Saharan African countries. Elsevier 2021-01-20 /pmc/articles/PMC7846921/ /pubmed/33554107 http://dx.doi.org/10.1016/j.conx.2021.100055 Text en © 2021 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Anglewicz, Philip Larson, Elizabeth Akilimali, Pierre Guiella, Georges Kayembe, Patrick Kibira, Simon P.S. Makumbi, Fredrick Radloff, Scott Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda |
title | Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda |
title_full | Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda |
title_fullStr | Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda |
title_full_unstemmed | Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda |
title_short | Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda |
title_sort | characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (dmpa-sc) in burkina faso, democratic republic of congo, and uganda |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846921/ https://www.ncbi.nlm.nih.gov/pubmed/33554107 http://dx.doi.org/10.1016/j.conx.2021.100055 |
work_keys_str_mv | AT anglewiczphilip characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda AT larsonelizabeth characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda AT akilimalipierre characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda AT guiellageorges characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda AT kayembepatrick characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda AT kibirasimonps characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda AT makumbifredrick characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda AT radloffscott characteristicsassociatedwithuseofsubcutaneousdepotmedroxyprogesteroneacetatedmpascinburkinafasodemocraticrepublicofcongoanduganda |